"SCOA offers a multitude of cancer treatment options such as medical oncology, radiation oncology, and also gynecologic oncology. The Cancer Center at South Carolina Oncology Associates also offers additional patient services including a full suite of diagnostic imaging services, a chemotherapy infusion suite, retail and infusion pharmacy services, social work, financial counseling, and a fully operational CLIA certified medical laboratory — all under one roof."

During the past decade, South Carolina Oncology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 45 clinical trials were completed, i.e. on average, 4500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Carolina Oncology Associates" #1 sponsor was "SCRI Development Innovations, LLC" with 25 trials, followed by "Celgene" with 4 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "National Cancer Institute (NCI)" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Carolina Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Bayer" with 6 trials as a collaborator, "Genentech, Inc." with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator and "GlaxoSmithKline" with 3 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "South Carolina Oncology Associates" are "Breast Cancer" (12 trials), "Metastatic Breast Cancer" (4 trials), "Multiple Myeloma" (4 trials), "Non Small Cell Lung Cancer" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "South Carolina Oncology Associates" in a lesser frequency.

Most popular intervention types in "South Carolina Oncology Associates" are "Drug" (81 trials), "Biological" (11 trials), "Other" (5 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (9 trials), "Bevacizumab" (8 trials), "Paclitaxel" (7 trials) and "Cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "South Carolina Oncology Associates" are 62 trials for "All" genders, 21 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "South Carolina Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in South Carolina Oncology Associates, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in South Carolina Oncology Associates, 5 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".